What is EUDA Health Holdings Ltd's earnings per share (EPS)?

EUDA Health Holdings Ltd (EUDA) reported diluted earnings per share of $-1.48 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

EUDA Health Holdings Ltd Financials

EUDA

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows EUDA Health Holdings Ltd (EUDA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EUDA FY2024 2026-04-28

EUDA’s business is financed outside the income statement, with persistent cash burn and very weak short-term liquidity.

From FY2022 through FY2024, operating cash flow stayed negative while financing cash flow stayed positive, even though revenue hovered around $4.0M; the business has been funded externally rather than by its own operations. That dependence matters because FY2024 current assets of $763K covered only a small slice of current liabilities of $4.14M, making liquidity tighter than the revenue line suggests.

The problem is not simply a sales slump: FY2024 revenue was slightly above FY2023, yet gross margin compressed from 22.7% to 19.0%, so each sale contributed less before overhead. With only $762K of gross profit, fixed costs appear oversized for this revenue base.

Even after total liabilities fell from $8.79M in FY2023 to $4.27M in FY2024, the current ratio was still just 0.2x because most obligations remained short-term. Negative equity means the balance sheet still carries a capital deficit, so the smaller liability stack did not translate into financial flexibility.

Financial Health Signals

Financial Profile 15/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of EUDA Health Holdings Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

EUDA Health Holdings Ltd has an operating margin of -36.3%, meaning the company retains $-36 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -432.2% the prior year.

Growth

EUDA Health Holdings Ltd's revenue surged 70.0% year-over-year to $6.8M, reflecting rapid business expansion. This strong growth earns a score of 93/100.

Leverage

EUDA Health Holdings Ltd has elevated debt relative to equity (D/E of -1.41), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

EUDA Health Holdings Ltd's current ratio of 0.18 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

While EUDA Health Holdings Ltd generated -$2.4M in operating cash flow, capex of $77K consumed most of it, leaving -$2.5M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Piotroski F-Score Neutral

5/9

EUDA Health Holdings Ltd passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality

0.88x

For every $1 of reported earnings, EUDA Health Holdings Ltd generates $0.88 in operating cash flow (-$2.4M OCF vs -$2.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-10.8x

EUDA Health Holdings Ltd earns $-10.8 in operating income for every $1 of interest expense (-$2.5M vs $229K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.8M

YoY+70.0%

EUDA Health Holdings Ltd generated $6.8M in revenue in fiscal year 2025. This represents an increase of 70.0% from the prior year.

EBITDA

-$2.3M

YoY+86.7%

EUDA Health Holdings Ltd's EBITDA was -$2.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 86.7% from the prior year.

Net Income

-$2.8M

YoY+81.9%

EUDA Health Holdings Ltd reported -$2.8M in net income in fiscal year 2025. This represents an increase of 81.9% from the prior year.

EPS (Diluted)

$-1.48

EUDA Health Holdings Ltd earned $-1.48 per diluted share (EPS) in fiscal year 2025. This represents an increase of 84.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$2.5M

YoY-17.5%

EUDA Health Holdings Ltd generated -$2.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 17.5% from the prior year.

Cash & Debt

$345K

YoY+45.3%

EUDA Health Holdings Ltd held $345K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

EUDA Health Holdings Ltd had 2M shares outstanding in fiscal year 2025. This represents a decrease of 94.9% from the prior year.

Margins & Returns

Gross Margin

43.9%

YoY+24.9pp

EUDA Health Holdings Ltd's gross margin was 43.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 24.9 percentage points from the prior year.

Operating Margin

-36.3%

YoY+395.9pp

EUDA Health Holdings Ltd's operating margin was -36.3% in fiscal year 2025, reflecting core business profitability. This is up 395.9 percentage points from the prior year.

Net Margin

-40.6%

YoY+342.2pp

EUDA Health Holdings Ltd's net profit margin was -40.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 342.2 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$249

EUDA Health Holdings Ltd invested $249 in research and development in fiscal year 2025.

Share Buybacks

N/A

Capital Expenditures

$77K

YoY-20.2%

EUDA Health Holdings Ltd invested $77K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 20.2% from the prior year.

EUDA Income Statement

Metric	FY25	FY24	FY23	FY22	FY21
Revenue	$6.8M+70.0%	$4.0M+8.2%	$3.7M-1.5%	$3.8M-17.4%	$4.6M
Cost of Revenue	$3.8M+17.8%	$3.2M+13.4%	$2.9M-1.0%	$2.9M-12.5%	$3.3M
Gross Profit	$3.0M+292.7%	$762K-9.5%	$842K-3.2%	$870K-30.4%	$1.2M
R&D Expenses	$249	N/A	N/A	$17K-86.7%	$129K
SG&A Expenses	$4.1M+29.2%	$3.2M-24.8%	$4.3M-26.6%	$5.8M+293.9%	$1.5M
Operating Income	-$2.5M+85.7%	-$17.3M-337.6%	-$4.0M+67.6%	-$12.2M-2082.0%	-$560K
Interest Expense	$229K+409.3%	$45K+93.3%	$23K	N/A	N/A
Income Tax	$42K+1057.6%	-$4K	N/A	-$21K-144.7%	$46K
Net Income	-$2.8M+81.9%	-$15.4M-53.0%	-$10.0M+59.7%	-$24.9M-2977.3%	$865K
EPS (Diluted)	$-1.48	$-9.46-7.9%	$-8.77-323.7%	$-2.07-2400.0%	$0.09

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q1'23	Q4'22
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	$1.7M	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	$1.3M	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	$404K	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	$2.0M	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	-$2.0M-562.6%	-$298K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	$985	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A	-$2.4M-1301.2%	$201K
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	$-0.12	N/A

EUDA Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21
Total Assets	$1.7M+1.1%	$1.7M+29.6%	$1.3M-94.9%	$25.6M+220.4%	$8.0M
Current Assets	$1.0M+36.2%	$763K+5.5%	$723K-97.1%	$25.0M+475.0%	$4.4M
Cash & Equivalents	$345K+45.3%	$238K+25.7%	$189K+228.5%	$58K-69.7%	$190K
Inventory	$3K-97.8%	$129K	N/A	N/A	N/A
Accounts Receivable	$243K+66.0%	$146K-38.4%	$237K+23.1%	$193K-89.3%	$1.8M
Goodwill	N/A	$0	$0	N/A	$993K
Total Liabilities	$6.0M+40.1%	$4.3M-51.4%	$8.8M-69.8%	$29.1M+293.8%	$7.4M
Current Liabilities	$5.8M+40.9%	$4.1M-52.5%	$8.7M-70.1%	$29.1M+298.0%	$7.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A
Total Equity	-$4.3M-66.7%	-$2.6M+66.0%	-$7.5M-113.0%	-$3.5M-775.4%	$521K
Retained Earnings	-$52.9M-5.5%	-$50.1M-44.2%	-$34.7M-40.6%	-$24.7M-13799.0%	$180K

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q1'23	Q4'22
Total Assets	$1.7M-19.1%	$2.1M+25.0%	$1.7M-16.3%	$2.0M+54.7%	$1.3M	N/A	$25.5M-70.8%	$87.3M
Current Assets	$1.0M-20.4%	$1.3M+71.3%	$763K-27.8%	$1.1M+46.0%	$723K	N/A	$24.8M-71.6%	$87.3M
Cash & Equivalents	$345K+95.5%	$177K-25.7%	$238K-36.8%	$376K+99.0%	$189K	N/A	$837K+214.9%	$266K
Inventory	$3K-97.6%	$117K-9.4%	$129K	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$243K-43.1%	$427K+191.9%	$146K-17.4%	$177K-25.5%	$237K	N/A	$1.6M	N/A
Goodwill	N/A	N/A	$0	N/A	$0	N/A	N/A	N/A
Total Liabilities	$6.0M+2.3%	$5.8M+37.0%	$4.3M-46.9%	$8.0M-8.6%	$8.8M	N/A	$31.4M-65.6%	$91.3M
Current Liabilities	$5.8M+2.2%	$5.7M+37.8%	$4.1M-47.5%	$7.9M-9.6%	$8.7M	N/A	$31.3M	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$4.3M-14.7%	-$3.7M-45.3%	-$2.6M+57.6%	-$6.0M+19.7%	-$7.5M-25.5%	-$6.0M-0.4%	-$6.0M-48.0%	-$4.0M
Retained Earnings	-$52.9M-3.1%	-$51.3M-2.4%	-$50.1M+2.9%	-$51.6M-48.4%	-$34.7M	N/A	-$27.1M-574.3%	-$4.0M

EUDA Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21
Operating Cash Flow	-$2.4M-19.3%	-$2.0M+30.3%	-$2.9M-91.1%	-$1.5M-443.9%	$444K
Capital Expenditures	$77K-20.2%	$97K	N/A	$18K+1547.3%	$1K
Free Cash Flow	-$2.5M-17.5%	-$2.1M	N/A	-$1.5M-448.9%	$443K
Investing Cash Flow	-$104K+29.3%	-$148K	N/A	-$268K+24.7%	-$356K
Financing Cash Flow	$2.6M+9.7%	$2.3M-1.2%	$2.4M-5.5%	$2.5M+1578.2%	-$168K
Dividends Paid	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q1'23	Q4'22
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	-$1.7M-263.2%	-$470K-279.6%	-$124K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	$1.2M+125.8%	$525K+167.9%	$196K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

EUDA Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21
Gross Margin	43.9%+24.9pp	19.0%-3.7pp	22.7%-0.4pp	23.1%-4.3pp	27.4%
Operating Margin	-36.3%+395.9pp	-432.2%-325.3pp	-106.9%+217.7pp	-324.6%-312.3pp	-12.3%
Net Margin	-40.6%+342.2pp	-382.9%-112.0pp	-270.9%+390.2pp	-661.1%-680.0pp	19.0%
Return on Equity	N/A	N/A	N/A	N/A	165.9%
Return on Assets	-161.5%+743.0pp	-904.5%-138.4pp	-766.1%-669.0pp	-97.1%-107.9pp	10.8%
Current Ratio	0.180.0	0.18+0.1	0.08-0.8	0.86+0.3	0.59
Debt-to-Equity	-1.41+0.3	-1.67-0.5	-1.17+7.1	-8.28-22.5	14.20
FCF Margin	-36.7%+16.4pp	-53.1%	N/A	-41.0%-50.7pp	9.7%

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q1'23	Q4'22
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	23.8%	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	-116.4%	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	-142.1%	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	-9.5%-9.7pp	0.2%
Current Ratio	0.18-0.1	0.23+0.0	0.18+0.1	0.13+0.1	0.08	N/A	0.79	N/A
Debt-to-Equity	-1.41+0.2	-1.58+0.1	-1.67-0.3	-1.33-0.2	-1.17	N/A	-5.28+17.4	-22.70
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$4.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.18), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Rafael Holdings RFL

$69.2M

CHG

$34.5M

Ohmyhome Limited OMH

$19.9M

Fangdd Network Group Ltd. DUO

$46.3M

American Strategic Investment Co. NYC

$26.6M

Frequently Asked Questions

What is EUDA Health Holdings Ltd's annual revenue?

EUDA Health Holdings Ltd (EUDA) reported $6.8M in total revenue for fiscal year 2025. This represents a 70.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is EUDA Health Holdings Ltd's revenue growing?

EUDA Health Holdings Ltd (EUDA) revenue grew by 70% year-over-year, from $4.0M to $6.8M in fiscal year 2025.

Is EUDA Health Holdings Ltd profitable?

No, EUDA Health Holdings Ltd (EUDA) reported a net income of -$2.8M in fiscal year 2025, with a net profit margin of -40.6%.

What is EUDA Health Holdings Ltd's EBITDA?

EUDA Health Holdings Ltd (EUDA) had EBITDA of -$2.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is EUDA Health Holdings Ltd's gross margin?

EUDA Health Holdings Ltd (EUDA) had a gross margin of 43.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is EUDA Health Holdings Ltd's operating margin?

EUDA Health Holdings Ltd (EUDA) had an operating margin of -36.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is EUDA Health Holdings Ltd's net profit margin?

EUDA Health Holdings Ltd (EUDA) had a net profit margin of -40.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is EUDA Health Holdings Ltd's free cash flow?

EUDA Health Holdings Ltd (EUDA) generated -$2.5M in free cash flow during fiscal year 2025. This represents a -17.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is EUDA Health Holdings Ltd's operating cash flow?

EUDA Health Holdings Ltd (EUDA) generated -$2.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are EUDA Health Holdings Ltd's total assets?

EUDA Health Holdings Ltd (EUDA) had $1.7M in total assets as of fiscal year 2025, including both current and long-term assets.

What are EUDA Health Holdings Ltd's capital expenditures?

EUDA Health Holdings Ltd (EUDA) invested $77K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does EUDA Health Holdings Ltd spend on research and development?

EUDA Health Holdings Ltd (EUDA) invested $249 in research and development during fiscal year 2025.

How many shares does EUDA Health Holdings Ltd have outstanding?

EUDA Health Holdings Ltd (EUDA) had 2M shares outstanding as of fiscal year 2025.

What is EUDA Health Holdings Ltd's current ratio?

EUDA Health Holdings Ltd (EUDA) had a current ratio of 0.18 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is EUDA Health Holdings Ltd's debt-to-equity ratio?

EUDA Health Holdings Ltd (EUDA) had a debt-to-equity ratio of -1.41 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is EUDA Health Holdings Ltd's return on assets (ROA)?

EUDA Health Holdings Ltd (EUDA) had a return on assets of -161.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is EUDA Health Holdings Ltd's cash runway?

Based on fiscal year 2025 data, EUDA Health Holdings Ltd (EUDA) had $345K in cash against an annual operating cash burn of $2.4M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is EUDA Health Holdings Ltd's debt-to-equity ratio negative or unusual?

EUDA Health Holdings Ltd (EUDA) has negative shareholder equity of -$4.3M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is EUDA Health Holdings Ltd's Piotroski F-Score?

EUDA Health Holdings Ltd (EUDA) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are EUDA Health Holdings Ltd's earnings high quality?

EUDA Health Holdings Ltd (EUDA) has an earnings quality ratio of 0.88x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can EUDA Health Holdings Ltd cover its interest payments?

EUDA Health Holdings Ltd (EUDA) has an interest coverage ratio of -10.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is EUDA Health Holdings Ltd?

EUDA Health Holdings Ltd (EUDA) scores 15 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.